Neuroscience-Based Nomenclature for Psychotropic Drugs: Four Reasons to Use and Keep it in Portugal

Authors

  • Afonso Gouveia Serviço de Psiquiatria. Unidade Local de Saúde do Baixo Alentejo. Beja; Comprehensive Health Research Centre (CHRC). NOVA Medical School. Universidade NOVA de Lisboa. Lisboa. https://orcid.org/0000-0002-3055-2063
  • Filipa Martins Serviço de Psiquiatria. Centro Hospitalar Universitário de São João. Porto; Centro de Investigação em Tecnologias e Serviços de Saúde – CINTESIS. Faculdade de Medicina. Universidade do Porto. Porto. https://orcid.org/0000-0002-6220-3124
  • Pedro Trindade Serviço de Psiquiatria. Centro Hospitalar de Lisboa Ocidental. Lisboa. https://orcid.org/0009-0007-2158-8594
  • Gustavo Jesus Faculdade de Medicina. Universidade de Lisboa. Lisboa; Partners in Neuroscience – PIN. Lisboa; Serviço de Psiquiatria. Hospital de Vila Franca de Xira (ULS Estuário do Tejo). Lisboa. https://orcid.org/0000-0002-3681-081X
  • João M. Bessa Faculdade de Medicina. Universidade de Lisboa. Lisboa; Partners in Neuroscience – PIN. Lisboa; Serviço de Psiquiatria. Hospital de Vila Franca de Xira (ULS Estuário do Tejo). Lisboa. https://orcid.org/0000-0001-6385-2452
  • Maria João Heitor Environmental Health Behaviour Lab. Instituto de Saúde Ambiental & Laboratório Associado TERRA. Faculdade de Medicina. Universidade de Lisboa; Departamento de Psiquiatria e Saúde Mental. Hospital Beatriz Ângelo. Loures; Centro de Investigação Interdisciplinar em Saúde – CIIS. Faculdade de Medicina. Universidade Católica Portuguesa. Lisboa. https://orcid.org/0000-0003-3481-091X
  • Luís Câmara Pestana Faculdade de Medicina. Universidade de Lisboa. Lisboa; Centro Hospitalar Universitário Lisboa Norte – CHULN. Lisboa. 
  • Luís Afonso Fernandes Departamento de Saúde Mental. Hospital Professor Doutor Fernando Fonseca EPE. Lisboa. https://orcid.org/0000-0001-5067-5450
  • Pedro Morgado Life and Health Sciences Research Institute – ICVS. Faculdade de Medicina. Universidade do Minho. Campus de Gualtar. Braga; Laboratório Associado ICVS/3B’s. Braga/Guimarães. https://orcid.org/0000-0003-3880-3258
  • Albino J. Oliveira-Maia Champalimaud Research and Clinical Centre. Fundação Champalimaud. Lisboa; NOVA Medical School. Faculdade de Ciências Médicas. Universidade NOVA de Lisboa. Lisboa. https://orcid.org/0000-0001-5071-3007

DOI:

https://doi.org/10.20344/amp.20267

Keywords:

Mental Disorders/drug therapy, Portugal, Psychotropic Drugs, Terminology as Topic

Abstract

N/a.

Downloads

Download data is not yet available.

References

World Health Organization. Anatomical Therapeutic Chemical (ATC) Classification. [consultado 2023 ago 22]. Disponível em: https://www.who.int/tools/atc-ddd-toolkit/atc-classification.

Zohar J, Blier P, Stahl S, Möller HJ, Kupfer D, Correll C, et al. NbNomenclature: neuroscience-based nomenclature [ebook]. 2nd ed revised. Bélgica: European College of Neuropsychopharmacology; 2019.

Zohar J, Nutt DJ, Kupfer DJ, Moller HJ, Yamawaki S, Spedding M, et al. A proposal for an updated neuropsychopharmacological nomenclature. Eur Neuropsychopharmacol. 2014;24:1005-14.

Zohar J, Levy DM. Neuroscience-based nomenclature of psychotropics: progress report. Eur Neuropsychopharmacol. 2022;57:36-8.

Zemach S, Minkin Levy D, Zohar J. Neuroscience-based nomenclature as a teaching tool, introduction and pilot study. Int Clin Psychopharmacol. 2023;38:329-35.

Volkow ND, Gordon JA, Koob GF. Choosing appropriate language to reduce the stigma around mental illness and substance use disorders. Neuropsychopharmacol. 2021;46:2230-2.

Evans D, Rodriguez C, First M, Martin G, Nemeroff C, Carpenter L, et al. Position Statement on Neuroscience-based Nomenclature (NbN) Project (APA Official Actions, pp. 1–2). American Psychiatric Association. [consultado 2023 ago 21]. Disponível em: https://www.psychiatry.org/File%20Library/About-APA/Organization-Documents-Policies/Policies/Position-Neuroscience-based-Nomenclature-NbN-Project.pdf.

Worley L. Neuroscience-based nomenclature (NbN). Lancet Psychiat. 2017;4:272-3.

Downloads

Published

2024-03-01

How to Cite

1.
Gouveia A, Martins F, Trindade P, Jesus G, M. Bessa J, Heitor MJ, Câmara Pestana L, Fernandes LA, Morgado P, Oliveira-Maia AJ. Neuroscience-Based Nomenclature for Psychotropic Drugs: Four Reasons to Use and Keep it in Portugal. Acta Med Port [Internet]. 2024 Mar. 1 [cited 2024 Nov. 22];37(3):155-9. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/20267

Issue

Vol. 37 No. 3 (2024): March

Section

Perspective

License

Copyright (c) 2024 Acta Médica Portuguesa

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.

Crossref
Scopus
Google Scholar
Europe PMC